Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lipidio Pharmaceuticals
AddedFeb 15, 2024
UpdatedJun 18, 2026
Lipidio Pharmaceuticals

Lipidio Pharmaceuticals

Series A

Lipidio Pharma: Advancing molecules for dermatological and metabolic diseases treatment.

HQ
San Diego, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Lipidio Pharmaceuticals, founded to address significant unmet medical needs, is dedicated to developing innovative treatments for dermatological and metabolic diseases. Their core mission is to advance molecules that can effectively treat conditions such as acne, sebaceous hyperplasia, nonalcoholic steatohepatitis (NASH), and obesity. By focusing on these prevalent health issues, Lipidio aims to improve patient outcomes and quality of life through cutting-edge pharmaceutical solutions.

Notable achievements for Lipidio Pharmaceuticals include presenting at prestigious conferences such as the BIOCOM Global Life Sciences Partnering Conference and the Dermatology Summit. The company has successfully closed a Series A extension financing round, raising over $20 million to further their research and development efforts. This financial backing and industry recognition underscore Lipidio's potential impact on the healthcare sector, particularly in addressing chronic dermatological and metabolic conditions.

Lipidio Pharmaceuticals - Similar Companies

OrsoBio logo

OrsoBio

orsobio.com

LipimetiX logo

LipimetiX

Resolvyx Pharmaceuticals logo

Resolvyx Pharmaceuticals

Lipocine logo

Lipocine

lipocine.com

Adipo Therapeutics logo

Adipo Therapeutics

Timber Pharmaceuticals logo

Timber Pharmaceuticals

Arcutis Biotherapeutics logo

Arcutis Biotherapeutics

arcutis.com

Eolo Pharma logo

Eolo Pharma

eolo-pharma.com

Lobesity Investors logo

Lobesity Investors

Lipella Pharmaceuticals logo

Lipella Pharmaceuticals

lipella.com

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

DermBiont logo

DermBiont

dermbiont.com

KinDex Pharmaceuticals logo

KinDex Pharmaceuticals

Aria Pharmaceuticals logo

Aria Pharmaceuticals

BodyBio logo

BodyBio

bodybio.co.uk

Lipidio Pharmaceuticals - Quick Facts

Who are Lipidio Pharmaceuticals' competitors?

Companies similar to Lipidio Pharmaceuticals include OrsoBio, LipimetiX, Resolvyx Pharmaceuticals and Lipocine.

When was Lipidio Pharmaceuticals founded?

Lipidio Pharmaceuticals was founded in 2018.

Where is Lipidio Pharmaceuticals' headquarters located?

Lipidio Pharmaceuticals' headquarters is located in San Diego, CA, US.

When was Lipidio Pharmaceuticals' last funding round?

Lipidio Pharmaceuticals' most recent funding round was for $20M (USD) in November 2022.

How much has Lipidio Pharmaceuticals raised to-date?

As of Nov 10, 2022, Lipidio Pharmaceuticals has raised a total of $20M (USD).

How many employees does Lipidio Pharmaceuticals have?

Lipidio Pharmaceuticals has 5 employees as of Feb 5, 2024.

Lipidio Pharmaceuticals - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified